Hakutulokset - Michael T. Nurmohamed

Tarkenna hakua
  1. 1
    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022

    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022 Tekijä Bas Dijkshoorn, Reinder Raadsen, Michael T. Nurmohamed

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice Tekijä Rabia Agca, Yvo M. Smulders, Michael T. Nurmohamed

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Management and evaluation of extra-articular manifestations in spondyloarthritis

    Management and evaluation of extra-articular manifestations in spondyloarthritis Tekijä Irene E. van der Horst‐Bruinsma, Michael T. Nurmohamed

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study

    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study Tekijä C. Krieckaert, Michael T. Nurmohamed, Gertjan Wolbink, Willem F. Lems

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study

    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study Tekijä Alper M. van Sijl, Maarten Boers, Alexandre E. Voskuyl, Michael T. Nurmohamed

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment Tekijä Ernest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, Zoltán Szekanecz, Michael T. Nurmohamed

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion

    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion Tekijä Inge A. M. van den Oever, Alper M. van Sijl, Michael T. Nurmohamed

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis Tekijä Michael T. Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Diana Dan

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus

    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus Tekijä Inge A. M. van den Oever, Hennie G. Raterman, Michael T. Nurmohamed, Suat Şimşek

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout

    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout Tekijä Romy Hansildaar, Daisy Vedder, Milad Baniaamam, Anne-Kathrin Tausche, Martijn Gerritsen, Michael T. Nurmohamed

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Is atherosclerosis an autoimmune disease?

    Is atherosclerosis an autoimmune disease? Tekijä Eiji Matsuura, Fabiola Atzeni, Piercarlo Sarzi‐Puttini, Maurizio Turiel, Luis R. Lopez, Michael T. Nurmohamed

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosi... Tekijä Debby den Uyl, Michael T. Nurmohamed, L. van Tuyl, Hennie G. Raterman, Willem F. Lems

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better

    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better Tekijä Matthew Peters, Alexandre E. Voskuyl, Naveed Sattar, Ben A. C. Dijkmans, Yvo M. Smulders, Michael T. Nurmohamed

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial Tekijä M. l’Ami, C. Krieckaert, Michael T. Nurmohamed, Ronald van Vollenhoven, Theo Rispens, Maarten Boers, Gertjan Wolbink

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review

    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review Tekijä Daisy Vedder, Wendy Walrabenstein, Maaike Heslinga, Ralph de Vries, Michael T. Nurmohamed, Dirkjan van Schaardenburg, Martijn Gerritsen

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes

    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes Tekijä Bart Seppen, Simone J. Verkleij, Jimmy Wiegel, Marieke M. ter Wee, Michael T. Nurmohamed, Wouter H Bos

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care

    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care Tekijä Markus M. J. Nielen, Alper M. van Sijl, Mike J. Peters, Robert Verheij, François Schellevis, Michael T. Nurmohamed

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.

    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Tekijä Vokko P. van Halm, Michael T. Nurmohamed, Jos W. R. Twisk, Ben A. C. Dijkmans, Alexandre E. Voskuyl

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis Tekijä J. Christiaan van Denderen, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene van der Horst‐Bruinsma

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement

    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement Tekijä Leonieke van Mens, M. Turina, M. G. H. Van de Sande, Michael T. Nurmohamed, Arno W. R. van Kuijk, Dominique Baeten

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: